Eli Lilly’s announcement that it will cut the price of insulin for people with commercial health insurance — capping out-of-pocket insulin costs to $35 — highlights just how much money people are paying on these injections.
The $35 monthly limit is what people with commercial health insurance plans using Lilly insulin will be paying at participating retail pharmacies, the drug maker said Wednesday. The 70% price cut will also reduce prices on its non-branded Insulin Lispro to $25 a vial.
The…
